Market Place
Sourcing Support
Clinigen notes results from the MIROCALS trial investigating low dose ProleukinÂ
08 Dec 2022 //
GLOBENEWSWIRE
Cancer drug could aid heart attack recovery
06 Sep 2021 //
FIRSTWORD PHARMA
Exelixis` Growth `Heavily` Depends on Success of Tumor Drugs Cabometyx, XL092
19 Jul 2021 //
PRESS RELEASE
Synthekine Launches with $82 Million Series A Financing to Advance Pipeline
17 Sep 2020 //
BIOSPACE
Clinigen signs agreement with Iovance Biotherapeutics
14 Jan 2020 //
PRESS RELEASE
Clinigen completes acquisition of US rights to Proleukin
02 Apr 2019 //
BIOSPACE
Clinigen buys U.S. rights to Novartis` cancer drug Proleukin
13 Feb 2019 //
REUTERS
Aldesleukin: CMDh Scientific conclusions & amendments to Product Info (EMA)
25 Oct 2018 //
EMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.